Image

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Assess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.

Description

The objective of this study is to assess the functionality of the Versus™ Catheter for the controlled and selective infusion of physician-specified fluids, including thrombolytics, into the pulmonary artery vasculature in adult patients, including advanced Computerized Tomography Angiogram (CTA) imaging assessment. This study will include an evaluation of patient outcomes and physician user experience with the Versus™ Catheter among up to 10 patients meeting the criteria for enrollment.

Eligibility

Inclusion Criteria:

  • Patients 18 - 80 years, inclusive
  • Patients who present with submassive pulmonary embolism (PE)
  • Patients requiring thrombolytic intervention to the pulmonary vasculature
  • Physician decision to use the Versus™ Catheter during the treatment of the patient

Exclusion Criteria:

  • Concurrent treatment with thrombectomy
  • Concurrent treatment with a catheter-directed thrombolysis device that is NOT the Versus™ Catheter
  • Massive pulmonary embolism (PE)
  • Active bleeding disorder1
  • Recent cerebrovascular accident or transient ischemic attack1
  • Recent neurosurgery1
  • Recent intracranial trauma1
  • Absolute contraindication to anticoagulation1
  • BMI > 45kg/m2
  • In the opinion of the investigator, the participant is not a suitable candidate for the study

Study details
    Blood Clots
    Vascular Disease
    Embolism Thrombosis
    Cardiovascular Diseases
    Lung Diseases

NCT06975969

Liquet Medical Inc.

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.